Cytokinetics
CYTK
CYTK
354 hedge funds and large institutions have $5.53B invested in Cytokinetics in 2025 Q1 according to their latest regulatory filings, with 56 funds opening new positions, 139 increasing their positions, 110 reducing their positions, and 44 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
2.83% more ownership
Funds ownership: 111.27% → 114.1% (+2.8%)
11% less capital invested
Capital invested by funds: $6.18B → $5.53B (-$654M)
20% less funds holding in top 10
Funds holding in top 10: 15 → 12 (-3)
Holders
354
Holding in Top 10
12
Calls
$184M
Puts
$45.7M
Top Buyers
| 1 | +$99.8M | |
| 2 | +$62.4M | |
| 3 | +$37.5M | |
| 4 |
PBA
Paradigm Biocapital Advisors
New York
|
+$34.5M |
| 5 |
Jennison Associates
New York
|
+$27.1M |
Top Sellers
| 1 | -$42.3M | |
| 2 | -$35M | |
| 3 | -$32M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$25.4M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$19.2M |